Retatrutide Pen

Retatrutide is a novel tri-agonist peptide that simultaneously targets three critical metabolic receptors: GLP-1, GIP, and glucagon. Originally developed for clinical research into obesity and metabolic disorders, it is designed to support extensive scientific exploration into weight reduction, improved glucose management, and enhanced metabolic function.

All products are exclusively sold for research purposes. They are not intended for human use, therapeutic, diagnostic, or clinical application.